IFPMA 2014 interview series ‘Vaccines missed opportunities’
Dr Joan Awunyo-Akaba: Representative of the civil society on the GAVI Alliance Board
Immunization: The Missed Opportunity
In this interview, Dr Joan Awunyo-Akaba, Gavi Civil Society Organizations (CSOs) Board Member gives her take on what “Immunization – the Missed Opportunity” is all about. She puts a special emphasis on how to reach that fifth child that is still not receiving the direly need immunization shots. By addressing immunization challenges, the international community can reduce the burden of vaccine-preventable diseases that affects the future of those children, sustain healthy communities, and reduce health disparities both within and across countries.
Bio: Dr Awunyo-Akaba has a PhD in medical sociology from the University of Ghana Legon (2007). She is a community health development consultant; Founder and Executive Director of Future Generations International (FUGI), a Ghanaian based NGO on health promotion and development; and an expert in childhood immunisation advocacy; behaviour change communication; and water, sanitation, and hygiene. A registered nurse, she is involved in civil society organisational activities, and is currently the National Vice Chairperson of the Ghana Coalition of NGOs in Health. Joan also represents the national Health Coalition on the Ghana Health Services’ Gavi Consortium that assesses the eligibility and involvement of CSOs in immunisation and health systems strengthening; and is presently advocating for the establishment of a National Innovative Fund for Childhood Immunization that would ensure the sustainability of the EPI in Ghana when Gavi support ends.
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Related news and resources
The value of prevention for economic growth and the sustainability of healthcare, social care and welfare systems (The European House – Ambrosetti)
Over the last decade, the EU economy has experienced slow growth, and it is not expected to grow substantially in the coming years. Additionally, the ongoing demographic and epidemiological transition is increasing pressure on public finances, particularly healthcare and social expenditure. The current permacrisis – encompassing geopolitical and climate-related challenges – exacerbates these issues and...
Read more
Only an urgent shift towards prevention-based healthcare can secure economic stability for EU health systems, experts say
As Governments of EU Member States present their medium-term fiscal structural plans on 20 September, a new report developed by The European House – Ambrosetti, supported by IFPMA and Vaccines Europe, notes that embedding preventative healthcare – in particular immunisation – into EU Member States’ fiscal policies is paramount to ensure the economic sustainability of...
Read morePharmaceutical industry welcomes the launch of Gavi’s new investment round and AVMA
On 20 June in Paris, Gavi, the Vaccine Alliance, the Government of France and the African Union – together with Team Europe partners, co-hosted The Global Forum for Vaccine Sovereignty and Innovation.
Read more